High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial

Kenneth Mahaffey; Marc Cohen; Jyotsna Garg; Elliott Antman; Neal Kleiman; Shaun Goodman; Lisa Berdan; Craig Reist; Anatoly Langer; Harvey White; Philip Aylward; Jacques Col; James Ferguson; Robert Califf

High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial

Kenneth Mahaffey, Marc Cohen, Jyotsna Garg, Elliott Antman, Neal Kleiman, Shaun Goodman, Lisa Berdan, Craig Reist, Anatoly Langer, Harvey White, Philip Aylward, Jacques Col, James Ferguson, Robert Califf

Research output: Contribution to journal › Article › peer-review

65 Citations (Scopus)

Original language	English
Article number	CC
Pages (from-to)	2594-2600
Number of pages	7
Journal	JAMA: Journal of the American Medical Association
Volume	294
Issue number	20
Publication status	Published - 2005

Cite this

Mahaffey, K., Cohen, M., Garg, J., Antman, E., Kleiman, N., Goodman, S., Berdan, L., Reist, C., Langer, A., White, H., Aylward, P., Col, J., Ferguson, J., & Califf, R. (2005). High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial. JAMA: Journal of the American Medical Association, 294(20), 2594-2600. Article CC.

@article{2c3f7326380f467389700f311c99cca7,

title = "High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial",

author = "Kenneth Mahaffey and Marc Cohen and Jyotsna Garg and Elliott Antman and Neal Kleiman and Shaun Goodman and Lisa Berdan and Craig Reist and Anatoly Langer and Harvey White and Philip Aylward and Jacques Col and James Ferguson and Robert Califf",

year = "2005",

language = "English",

volume = "294",

pages = "2594--2600",

journal = "JAMA: Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Assocation",

number = "20",

}

Mahaffey, K, Cohen, M, Garg, J, Antman, E, Kleiman, N, Goodman, S, Berdan, L, Reist, C, Langer, A, White, H, Aylward, P, Col, J, Ferguson, J & Califf, R 2005, 'High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial', JAMA: Journal of the American Medical Association, vol. 294, no. 20, CC, pp. 2594-2600.

High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial. / Mahaffey, Kenneth; Cohen, Marc; Garg, Jyotsna et al.
In: JAMA: Journal of the American Medical Association, Vol. 294, No. 20, CC, 2005, p. 2594-2600.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial

AU - Mahaffey, Kenneth

AU - Cohen, Marc

AU - Garg, Jyotsna

AU - Antman, Elliott

AU - Kleiman, Neal

AU - Goodman, Shaun

AU - Berdan, Lisa

AU - Reist, Craig

AU - Langer, Anatoly

AU - White, Harvey

AU - Aylward, Philip

AU - Col, Jacques

AU - Ferguson, James

AU - Califf, Robert

PY - 2005

Y1 - 2005

M3 - Article

SN - 0098-7484

VL - 294

SP - 2594

EP - 2600

JO - JAMA: Journal of the American Medical Association

JF - JAMA: Journal of the American Medical Association

IS - 20

M1 - CC

ER -